Curium Finland Oy was founded in 1991 (Originally named MAP Medical Technologies Oy). The Company runs GMP facilities in two cities and possess wholesale distributor authorisation of medicinal products in Finland. In 2019 the company was acquired by Curium.
MAP Medical Technologies Oy was founded in 1991. Company runs GMP facilities in two cities and possess wholesale distributor authorisation of medicinal products in Finland. In 2019 the company was acquired by Curium.
Curium is the world’s largest nuclear medicine company. We develop, manufacture and distribute world-class radiopharmaceutical products to help patients around the globe. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service.
With manufacturing facilities across Europe and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for potentially life-threatening diseases to over 14 million patients annually. The name ‘Curium’ honors the legacy of pioneering radioactive materials researchers Marie and Pierre Curie, after whom the radioactive element curium was named and emphasizes our focus on nuclear medicine. The tagline ‘Life Forward’ represents our commitment to securing a brighter future for all those we serve: An enhanced quality of care for our patients. A trusted partner to our customers. A supportive employer to our valued team.
To learn more, visit www.curiumpharma.com